Novel clostridium botulinum toxin and dual use research of concern issues.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed.

1. Biosecurity in an age of open science.PLoS biology · 2022
   Article
2. Rapid Proliferation of Pandemic Research: Implications for Dual-Use Risks.mBio · 2021
   Article
3. Information Hazards in Biotechnology.Risk analysis : an official publication of the Society for Risk Analysis · 2019
   Article
4. Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics.Toxins · 2018
   Review
5. A New Approach to Evaluating the Risk-Benefit Equation for Dual-Use and Gain-of-Function Research of Concern.Frontiers in bioengineering and biotechnology · 2018
   Article
6. Reoccurrence of botulinum neurotoxin subtype A3 inducing food-borne botulism, Slovakia, 2015.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2017
   Article
7. Biological Dual-Use Research and Synthetic Biology of Yeast.Science and engineering ethics · 2017
   Article
8. Dual-Use Research of Concern (DURC) Review at American Society for Microbiology Journals.mBio · 2015
   Article
9. Evolution of different dual-use concepts in international and national law and its implications on research ethics and governance.Science and engineering ethics · 2014
   Review
10. On the need for a national board to assess dual use research of concern.Journal of virology · 2014
    Article
11. Why has Not There been More Research of Concern?Frontiers in public health · 2014
    Article
12. Redaction of sensitive data in the publication of dual use research of concern.mBio · 2013
    Article

Corrections and comments

• Commented on by
  Validity of botulinum neurotoxin serotype H.2014
• Commented on by
  Clarification regarding novel Clostridium botulinum toxin.2014

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as